Search research articles
Contact Us
Filters
Showing results (21-30 of 39) with videos related to
Page
of 4
Sort By:
Journal of Addiction Medicine
|
February 11, 2020
Secondary Analysis of Pain Outcomes in a Large Pragmatic Randomized Trial of Buprenorphine/Naloxone Versus Methadone for Opioid Use Disorder
Matisyahu Shulman, Sean X Luo, Aimee N C Campbell, et al.
Journal of Substance Use and Addiction Treatment
|
December 9, 2025
A clinical trial loses access to some of its experimental treatment conditions: What can be done?
Sarah Meyers-Ohki, Matisyahu Shulman, Roger D Weiss, et al.
Drug and Alcohol Dependence
|
September 8, 2022
Buprenorphine & methadone dosing strategies to reduce risk of relapse in the treatment of opioid use disorder
Kara E Rudolph, Nicholas T Williams, Alicia T Singham Goodwin, et al.
Addiction (Abingdon, England)
|
December 19, 2020
Explaining differential effects of medication for opioid use disorder using a novel approach incorporating mediating variables
Kara E Rudolph, Iván Díaz, Nima S Hejazi, et al.
Journal of Addiction Medicine
|
October 3, 2023
Secondary Analysis of Agreement Between Negative Timeline Follow Back Report and Negative Urine Toxicology in a Large Trial of Individuals with Opioid Use Disorder
Matisyahu Shulman, Tse-Hwei Choo, Jennifer Scodes, et al.
Drug and Alcohol Dependence
|
May 23, 2022
Methamphetamine/amphetamine use over time among persons with opioid use disorders treated with buprenorphine/naloxone versus extended-release naltrexone
Judith I Tsui, Aimee N C Campbell, Martina Pavlicova, et al.
Substance Use & Misuse
|
April 3, 2026
Patient Characteristics Associated with Successful Initiation of Extended-Release Naltrexone in the X:BOT Trial
Kenzie Potter, Miranda Greiner, Matisyahu Shulman, et al.
European Journal of Dental Education : Official Journal of the Association for Dental Education in Europe
|
January 20, 2021
The utility of a formative one-station objective structured clinical examination for Substance use disorders in a dental curriculum
Folarin Odusola, Jennifer L Smith, Eva Turrigiano, et al.
Journal of Substance Abuse Treatment
|
March 27, 2021
Association between methadone or buprenorphine use during medically supervised opioid withdrawal and extended-release injectable naltrexone induction failure
Matisyahu Shulman, Tse-Hwei Choo, Jennifer Scodes, et al.
Journal of Substance Abuse Treatment
|
June 7, 2021
Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapse
Miranda G Greiner, Matisyahu Shulman, Tse-Hwei Choo, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 39) with videos related to
Sort By:
Page
of 4
Journal of Addiction Medicine
|
February 11, 2020
Secondary Analysis of Pain Outcomes in a Large Pragmatic Randomized Trial of Buprenorphine/Naloxone Versus Methadone for Opioid Use Disorder
Matisyahu Shulman, Sean X Luo, Aimee N C Campbell, et al.
Journal of Substance Use and Addiction Treatment
|
December 9, 2025
A clinical trial loses access to some of its experimental treatment conditions: What can be done?
Sarah Meyers-Ohki, Matisyahu Shulman, Roger D Weiss, et al.
Drug and Alcohol Dependence
|
September 8, 2022
Buprenorphine & methadone dosing strategies to reduce risk of relapse in the treatment of opioid use disorder
Kara E Rudolph, Nicholas T Williams, Alicia T Singham Goodwin, et al.
Addiction (Abingdon, England)
|
December 19, 2020
Explaining differential effects of medication for opioid use disorder using a novel approach incorporating mediating variables
Kara E Rudolph, Iván Díaz, Nima S Hejazi, et al.
Journal of Addiction Medicine
|
October 3, 2023
Secondary Analysis of Agreement Between Negative Timeline Follow Back Report and Negative Urine Toxicology in a Large Trial of Individuals with Opioid Use Disorder
Matisyahu Shulman, Tse-Hwei Choo, Jennifer Scodes, et al.
Drug and Alcohol Dependence
|
May 23, 2022
Methamphetamine/amphetamine use over time among persons with opioid use disorders treated with buprenorphine/naloxone versus extended-release naltrexone
Judith I Tsui, Aimee N C Campbell, Martina Pavlicova, et al.
Substance Use & Misuse
|
April 3, 2026
Patient Characteristics Associated with Successful Initiation of Extended-Release Naltrexone in the X:BOT Trial
Kenzie Potter, Miranda Greiner, Matisyahu Shulman, et al.
European Journal of Dental Education : Official Journal of the Association for Dental Education in Europe
|
January 20, 2021
The utility of a formative one-station objective structured clinical examination for Substance use disorders in a dental curriculum
Folarin Odusola, Jennifer L Smith, Eva Turrigiano, et al.
Journal of Substance Abuse Treatment
|
March 27, 2021
Association between methadone or buprenorphine use during medically supervised opioid withdrawal and extended-release injectable naltrexone induction failure
Matisyahu Shulman, Tse-Hwei Choo, Jennifer Scodes, et al.
Journal of Substance Abuse Treatment
|
June 7, 2021
Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapse
Miranda G Greiner, Matisyahu Shulman, Tse-Hwei Choo, et al.
Page
of 4